Viewing Study NCT07432867


Ignite Creation Date: 2026-03-26 @ 3:18 PM
Ignite Modification Date: 2026-04-05 @ 8:54 AM
Study NCT ID: NCT07432867
Status: RECRUITING
Last Update Posted: 2026-03-04
First Post: 2026-01-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy Safety Study of Gene Therapy for Sickle Cell DiseaseSCD Using Autologous CD34+ Cells Transduced ex Vivo, Carrying a Corrected Globin Gene and a Silencing RNA.
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module